Justin Kim
Stock Analyst at Oppenheimer
(4.30)
# 1,304
Out of 4,376 analysts
101
Total ratings
49.6%
Success rate
13.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Justin Kim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Rated: Buy | $63 → $110 | $74.48 | +47.69% | 6 | Apr 30, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $16 → $15 | $3.40 | +341.18% | 3 | Mar 20, 2026 | |
| IMCR Immunocore Holdings | Maintained: Buy | $85 → $86 | $28.29 | n/a | 10 | May 8, 2025 | |
| CYTK Cytokinetics | Maintained: Buy | $54 → $96 | $71.48 | n/a | 10 | Feb 28, 2025 | |
| ALDX Aldeyra Therapeutics | Reiterated: Buy | $12 | $1.63 | n/a | 21 | Oct 3, 2024 | |
| VERA Vera Therapeutics | Reiterated: Buy | $34 | $32.29 | n/a | 1 | Jan 26, 2024 | |
| PHVS Pharvaris | Rated: Buy | $26 | $31.09 | n/a | 8 | Nov 10, 2023 | |
| AUPH Aurinia Pharmaceuticals | Maintained: Hold | n/a | $15.84 | n/a | 28 | Aug 8, 2023 | |
| BCRX BioCryst Pharmaceuticals | Maintained: Hold | n/a | $8.41 | n/a | 6 | Dec 15, 2022 | |
| ELTX Elicio Therapeutics | Downgraded: Hold | n/a | $13.18 | n/a | 8 | Jun 30, 2022 |
Ionis Pharmaceuticals
Apr 30, 2026
Rated: Buy
Price Target: $63 → $110
Current: $74.48
Upside: +47.69%
Zura Bio
Mar 20, 2026
Reiterated: Buy
Price Target: $16 → $15
Current: $3.40
Upside: +341.18%
Immunocore Holdings
May 8, 2025
Maintained: Buy
Price Target: $85 → $86
Current: $28.29
Upside: n/a
Cytokinetics
Feb 28, 2025
Maintained: Buy
Price Target: $54 → $96
Current: $71.48
Upside: n/a
Aldeyra Therapeutics
Oct 3, 2024
Reiterated: Buy
Price Target: $12
Current: $1.63
Upside: n/a
Vera Therapeutics
Jan 26, 2024
Reiterated: Buy
Price Target: $34
Current: $32.29
Upside: n/a
Pharvaris
Nov 10, 2023
Rated: Buy
Price Target: $26
Current: $31.09
Upside: n/a
Aurinia Pharmaceuticals
Aug 8, 2023
Maintained: Hold
Price Target: n/a
Current: $15.84
Upside: n/a
BioCryst Pharmaceuticals
Dec 15, 2022
Maintained: Hold
Price Target: n/a
Current: $8.41
Upside: n/a
Elicio Therapeutics
Jun 30, 2022
Downgraded: Hold
Price Target: n/a
Current: $13.18
Upside: n/a